Isolated hepatic perfusion chemotherapy for unresectable malignant hepatic tumors

International Journal of Clinical Oncology

Volumn 7, Issue 2, 2002, Pages 82-90

  Ku, Y ^a   Tominaga, M ^a   Iwasaki, T ^a   Fukumoto, T ^a   Kuroda, Y ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Colorectal hepatic metastasis; Hepatic arterial infusion; Hepatocellular carcinoma; High dose chemotherapy; Isolated hepatic perfusion

Indexed keywords

ANTIINFLAMMATORY AGENT; CISPLATIN; DOXORUBICIN; FLUOROURACIL; INDOMETACIN; MELPHALAN; MITOMYCIN C; RECOMBINANT TUMOR NECROSIS FACTOR; STEROID; TUMOR NECROSIS FACTOR; ANTINEOPLASTIC AGENT;

CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; DRUG RESPONSE; HEPATIC ARTERY; HISTORY OF MEDICINE; HUMAN; HYPERTHERMIC THERAPY; INTERMETHOD COMPARISON; ISOLATED LIVER PERFUSION; LIVER CANCER; LIVER CELL CARCINOMA; LIVER METASTASIS; LIVER PERFUSION; MINIMALLY INVASIVE SURGERY; PORTAL VEIN; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; TREATMENT OUTCOME; LIVER TUMOR; METHODOLOGY; PATHOLOGY; REGIONAL PERFUSION;

ANTINEOPLASTIC AGENTS; CARCINOMA, HEPATOCELLULAR; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; CLINICAL TRIALS; HUMANS; LIVER NEOPLASMS;

EID: 0036001427     PISSN: 13419625     EISSN: None     Source Type: Journal    
DOI: 10.1007/s101470200011     Document Type: Review

References (72)

1. Predictive factors for long term prognosis after partial hepatectomy for patients with hepatocellular carcinoma in Japan
2. Primary hepatic malignancy: Surgical management and determinants of survival
3. Results of surgical resection for hepatocellular carcinoma
4. Limited hepatic resection for selected cirrhotic patients with hepatocellular or cholangiocellular carcinoma: A prospective study
5. Are there indications for intraarterial hepatic chemotherapy or isolated liver perfusion? The case of liver metastases from colorectal cancer
6. Liver resections in cirrhotic patients: A Western experience
7. Approach to primary liver cancer
8. Hepatic resection for hepatocellular carcinoma
9. Natural history of hepatocellular carcinoma in Spain. Five years experience in 249 cases
10. Intrahepatic recurrence after resection of hepatocellular carcinoma complicating cirrhosis
11. Hepatic resection for hepatocellular carcinoma. Clinical features and long term prognosis
12. Surgical treatment of 109 patients with symptomatic and asymptomatic hepatocellular carcinoma
13. Small hepatocellular carcinoma: Percutaneous alcohol injection-results in 23 patients
14. Percutaneous ethanol injection for the treatment of small hepatocellular carcinoma. Study of 95 patients
15. Factors that predict intrahepatic recurrence of hepatocellular carcinoma in 81 patients initially treated by ethanol injection
16. Intraoperative microwave tissue coagulation as treatment for patients with nonresectable hepatocellular carcinoma
17. Small hepatocellular carcinoma: Treatment with radio-frequency ablation versus ethanol injection
18. Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies
19. Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis
20. Clinical evaluation of intermittent arterial infusion chemotherapy with an implanted reservoir for hepatocellular carcinoma
21. The effectiveness of hepatic artery infusion in treatment of primary hepatobiliary tumors
22. Clinical trials in primary hepatocellular carcinoma: Current status and future directions
23. Intraarterial chemotherapy with FAM for metastatic liver cancers-a phase II study
24. A follow-up guideline and early detection of hepatic metastasis after resection of colorectal cancer
25. Prospective study of prognostic factors in patients with unresected hepatic metastases from colorectal cancer
26. Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma
27. A prospective randomized trial of regional versus systemic continuous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases
28. A randomized trial of continuous intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver
29. Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: Long-term results of a prospective randomized trial
30. Quality of life and survival with continuous hepatic artery floxuridine infusion for colorectal liver metastases
31. Regional versus systemic chemotherapy in the treatment of colorectal carcinoma metastatic to the liver: Is there a survival difference? Meta-analysis of the published literature
32. Reappraisal of hepatic arterial infusion in the treatment of nonresectable liver metastases from colorectal cancer
33. Isolated hyperthermic liver perfusion with chemotherapy for liver malignancy
34. Isolated hepatic perfusion with tumor necrosis factor alpha and melphalan: Experimental studies in pigs and phase I data from humans
35. Phase I/II studies of isolated hepatic perfusion with mitomycin C or melphalan in patients with colorectal hepatic metastases
36. First experience and technical aspects of isolated liver perfusion for extensive liver metastasis
37. Isolated hepatic perfusion for unresectable hepatic metastases from colorectal cancer
38. Single catheter technique of hepatic venous isolation and extracorporeal charcoal hemoperfusion for malignant liver tumors
39. Percutaneous hepatic vein isolation and high-dose hepatic arterial infusion chemotherapy for unresectable liver tumors
40. Fractionated intra-arterial cancer chemotherapy with methyl bis amine hydrochloride
41. Chemotherapy of cancer: Regional perfusion utilizing an extracorporeal circuit
42. Hepatic tissue tolerance to Thio-TEPA administered by the isolation-perfusion technique
43. The development of a technique for isolated perfusion of the liver
44. A study on selective hepatic perfusion of an antitumor agent as a regional chemotherapy for advanced malignancies in the liver
45. Isolated liver perfusion with MMC/5-FU: Surgical technique, pharmacokinetics, clinical results
46. Extracorporeal adriamycin removal following hepatic arterial infusion: Use of direct hemoperfusion combined with veno-venous bypass
47. Hepatic arterial infusion chemotherapy with complete hepatic venous isolation and extracorporeal chemofiltration: A feasibility study of a novel system
48. Percutaneous isolated liver perfusion for treament of hepatic malignancy: Preliminary report
49. Extracorporeal removal of anticancer drugs in hepatic arterial infusion: The effect of direct hemoperfusion combined with veno-venous bypass
50. Extracorporeal cisplatin removal using direct hemoperfusion under hepatic venous isolation for hepatic arterial chemotherapy: An experimental study on pharmacokinetics
51. Effect of sodium thiosulfate on cisplatin removal with complete hepatic venous isolation and extracorporeal charcoal hemoperfusion: A pharmacokinetic evaluation
52. Pharmacokinetic evaluation of percutaneous hepatic venous isolation for administration of regional chemotherapy
53. Clinical pilot study on high-dose intra-arterial chemotherapy with direct hemoperfusion under hepatic venous isolation in patients with advanced hepatocellular carcinoma
54. Complete hepatic venous isolation and extracorporeal chemofiltration as treatment for human hepatocellular carcinoma: A phase I study
55. Induction of long-term remission in advanced hepatocellular carcinoma with percutaneous isolated liver chemoperfusion
56. Isolated limb perfusion with tumor necrosis factor and melphalan for limb salvage in 186 patients with locally advanced soft tissue extremity sarcomas
57. Chemotherapy of brain cancer: Experimental and clinical studies in localized hypothermic cerebral perfusion
58. Super high-dose intraarterial CDDP infusion under percutaneous pelvic perfusion with extracorporeal chemofiltration for advanced uterine cervical carcinoma: II. Its impact on clinical response and survival
59. Isolated hepatic perfusion with tumor necrosis factor and melphalan for unresectable cancers confined to the liver
60. The blood supply of experimental liver metastases. IV. Changes in vascularity with increasing tumor growth
61. Postmortem examination of the blood supply and vascular pattern of small liver metastases in man
62. Simple method of hyperthermo-chemo-hypoxic isolated liver perfusion for hepatic metastases
63. Anethesiological management during isolated liver perfusion
64. Long-term results of percutaneous isolated hepatic perfusion for advanced hepatocellular carcinoma
65. A multidisciplinary treatment approach for multiple advanced hepatic cancer: A combination of surgical resection and percutaneous isolated hepatic perfusion
66. Surgical intervention for patients with stage IV-A hepatocellular carcinoma without lymph node metastasis
67. Die isolierte leberperfusion mit 5-fluorouracil (5-FU) beim menschen
68. Rationale and indications for perfusion in liver tumors: Current data
69. Percutaneous hepatic venous isolation and extracorporeal charcoal hemoperfusion for high-dose intraarterial chemotherapy in patients with colorectal hepatic metastases
70. Percutaneous isolated liver chemoperfusion for treatment of malignant liver tumors: Technique, pharmacokinetics, clinical results
71. Percutaneous isolated hepatic perfusion for treatment of colorectal hepatic metastases